January 9, 2020 8:11am

News: Applied Genetic Technologies Corporation (AGTC) reported positive interim six-month data from its ongoing P1/2 clinical program in X-linked retinitis pigmentosa (XLRP). AGTC is UP +$2.63 or +63.22% in the pre-market.

Pre-open indications:  flashing a warning, you’d be aware if a subscriber

My version of the morning’s numbers is written to be informative; it’s includes what happened or will beyond the headline and shapes today’s markets as seen by RMi - SUBSCRIBE

Members only. Please login.